As part of its work to evaluate the revalidation scheme, KPMG are looking into the costs, benefits, risks and equality impact of the draft revalidation scheme.
Two reports have been produced, one of which is available now. Information specification for the evaluation and impact assessment of the GOsC revalidation pilot is a detailed specification of the information to be collected during the pilot to update anticipated costs and benefits and risks analysis. It includes consideration of the involvement of public and patients in identifying costs, benefits and risks.
A report setting out anticipated costs, benefits, financial and regulatory risks as envisaged at pre-pilot development will be available here soon.